Clinical Trial

A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

Name: A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers — clinical trial record (NCT06951880)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The main purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) of AZD4916 in healthy adult participants.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-23.

Trial Details

NCT Number	NCT06951880
Lead Sponsor	AstraZeneca Collaborators: Parexel
Conditions	Healthy Participants
Enrollment	160 participants
Start Date	2026-07-23
Primary Completion	2027-10-25 (estimated)
Study Completion	2027-10-25 (estimated)
Updated on ClinicalTrials.gov	2026-06-15